TD Ameritrade Investment Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-284
Closed -$16K 613
2022
Q1
$16K Buy
284
+252
+788% +$13.5K ﹤0.01% 438
2021
Q4
$2K Sell
32
-10,662
-100% -$523K ﹤0.01% 583
2021
Q3
$502K Buy
10,694
+2,109
+25% +$114K ﹤0.01% 157
2021
Q2
$490K Buy
8,585
+118
+1% +$6.89K ﹤0.01% 169
2021
Q1
$453K Hold
8,467
﹤0.01% 160
2020
Q4
$453K Sell
8,467
-2,227
-21% -$116K ﹤0.01% 160
2020
Q3
$502K Sell
10,694
-442
-4% -$22.7K ﹤0.01% 157
2020
Q2
$581K Sell
11,136
-1,609
-13% -$82.9K ﹤0.01% 148
2020
Q1
$611K Buy
12,745
+2,814
+28% +$146K 0.01% 147
2019
Q4
$502K Buy
+9,931
New +$513K ﹤0.01% 169
2019
Q3
Sell
-369
Closed -$17K 636
2019
Q2
$17K Buy
+369
New +$17K ﹤0.01% 344
2019
Q1
Sell
-153
Closed -$7K 576
2018
Q4
$7K Buy
+153
New +$7.97K ﹤0.01% 400

Other funds holding CAH

TD Ameritrade Investment Management's CAH Position: Q2 2022 in Review

TD Ameritrade Investment Management sold out of Cardinal Health (CAH) in Q2 2022, closing a stake of 284 shares — an estimated $16K sold.

TD Ameritrade Investment Management first reported a position in CAH in Q4 2018 and held it in 12 quarters. The position peaked at $611K in Q1 2020. 792 funds tracked by Wall St. Rank hold CAH as of Q2 2022.

  • TD Ameritrade Investment Management reported no remaining Cardinal Health position as of Q2 2022 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 284 Cardinal Health shares in Q2 2022, an estimated $16K.
  • TD Ameritrade Investment Management first reported a position in Cardinal Health in Q4 2018 and held it in 12 quarters.
  • TD Ameritrade Investment Management's Cardinal Health position peaked at $611K in Q1 2020.
  • 792 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2022.

Based on TD Ameritrade Investment Management's 13F filing for Q2 2022, filed 9 Aug 2022.